Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6

Medical and Pediatric Oncology

Volumn 29, Issue 4, 1997, Pages 239-244

  Carli, M ^a   Frascella, E ^a   Tournade, M F ^a   De Kraker, J ^a   Rey, A ^a   Guzzinati, S ^a   Marion, J ^a   Burgers, V ^a   Delemarre, J F M ^a   Masiero, L ^a   Simonato, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Second malignancy; Wilms tumor

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CHILD; CHONDROSARCOMA; FEMALE; FOLLOW UP; HISTIOCYTIC LYMPHOMA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROECTODERM TUMOR; OSTEOSARCOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; WILMS TUMOR;

EID: 0030811553     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199710)29:4<239::AID-MPO1>3.0.CO;2-N     Document Type: Article

References (28)